To test whether the podocyte-specific induction of KLF6 attenuates DKD, NPHS2-rtTA and KLF6PODTA mice underwent uninephrectomy (UNx) with subsequent low-dose streptozotocin (STZ) treatment (Fig. 1a). This evidence concerns the gene KLF6 and diabetic kidney disease.